Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study

Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study ab...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 96; no. 26; p. e7285
Main Authors Guizard, Anne-Valerie N., Dejardin, Olivier J., Launay, Ludivine C., Bara, Simona, Lapôtre-Ledoux, Bénédicte M., Babin, Emmanuel B., Launoy, Guy D., Ligier, Karine A.
Format Journal Article
LanguageEnglish
Published United States The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved 01.06.2017
Wolters Kluwer Health
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.
AbstractList Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.
Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.
Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it. A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010. The tumors were diagnosed late (70.3% stage III–IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11–7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02–3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12–2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23–2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%. Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.
Author Dejardin, Olivier J.
Ligier, Karine A.
Lapôtre-Ledoux, Bénédicte M.
Bara, Simona
Launoy, Guy D.
Launay, Ludivine C.
Guizard, Anne-Valerie N.
Babin, Emmanuel B.
AuthorAffiliation Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France
AuthorAffiliation_xml – name: Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France
– name: a Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen
– name: d Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville
– name: f Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen
– name: g Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France
– name: b Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen
– name: e Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens
– name: c U1086 Inserm – Université Caen Basse Normandie
Author_xml – sequence: 1
  givenname: Anne-Valerie
  surname: Guizard
  middlename: N.
  fullname: Guizard, Anne-Valerie N.
  organization: Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France
– sequence: 2
  givenname: Olivier
  surname: Dejardin
  middlename: J.
  fullname: Dejardin, Olivier J.
– sequence: 3
  givenname: Ludivine
  surname: Launay
  middlename: C.
  fullname: Launay, Ludivine C.
– sequence: 4
  givenname: Simona
  surname: Bara
  fullname: Bara, Simona
– sequence: 5
  givenname: Bénédicte
  surname: Lapôtre-Ledoux
  middlename: M.
  fullname: Lapôtre-Ledoux, Bénédicte M.
– sequence: 6
  givenname: Emmanuel
  surname: Babin
  middlename: B.
  fullname: Babin, Emmanuel B.
– sequence: 7
  givenname: Guy
  surname: Launoy
  middlename: D.
  fullname: Launoy, Guy D.
– sequence: 8
  givenname: Karine
  surname: Ligier
  middlename: A.
  fullname: Ligier, Karine A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28658124$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9v1DAQxS1URLeFT4CEfOTi4r9xwgGp6lJAasUFztbEcTamib3YSat-e7y7pSq94Iulmd-bsd87QUchBofQW0bPGG30h-v1GX1yNK_VC7RiSlRENZU8QitKuSK60fIYneT8i1ImNJev0DGvK1UzLlcorD1sQsw-YwgdniDAxk0uzDj2eHDQ7cvB2RtsIViXMvYBAx78ZiA-WN-5UsWQHOwal2kHfcTneBu3ywizj4G0kF2H87x096_Ryx7G7N483Kfo5-XnHxdfydX3L98uzq-IlVRxUoNkvVWq0X1LGYeeWgYN51pC3SrphATn-kq3XAJr6qowVFZUKqjB9gDiFH06zN0u7eQ6Wz6UYDTb5CdI9yaCN_92gh_MJt4apYqVsioD3j8MSPH34vJsJp-tG0cILi7ZsIbJWmolREHfPd31uOSvyQUQB8CmmHNy_SPCqNlFaa7X5nmURdU8U1k_7w0tD_bjf7TyoL2L41wyuxmXO5dMyXOchz2udMMJp0zTSlBKSkVw8Qd8O7ID
CitedBy_id crossref_primary_10_1186_s12957_024_03407_4
crossref_primary_10_3390_cancers14122968
crossref_primary_10_4102_phcfm_v15i1_3749
crossref_primary_10_1021_acs_bioconjchem_3c00406
crossref_primary_10_1177_00034894221086087
crossref_primary_10_3390_jcm13082439
crossref_primary_10_18632_oncotarget_25284
crossref_primary_10_1007_s11654_023_00501_z
crossref_primary_10_1097_MD_0000000000029880
crossref_primary_10_1007_s00405_021_07118_4
crossref_primary_10_3390_jcm12124039
crossref_primary_10_1200_GO_22_00073
crossref_primary_10_1590_1807_3107bor_2023_vol37_0015
crossref_primary_10_17650_1818_8346_2021_16_3_105_117
crossref_primary_10_3166_s11839_017_0634_x
crossref_primary_10_1016_j_oraloncology_2022_106278
crossref_primary_10_3892_etm_2022_11291
crossref_primary_10_1097_PPO_0000000000000671
crossref_primary_10_3892_ol_2018_9298
crossref_primary_10_1371_journal_pone_0202897
crossref_primary_10_1016_j_bjorl_2021_04_008
crossref_primary_10_3389_froh_2022_827360
crossref_primary_10_1097_MD_0000000000017472
Cites_doi 10.1002/ijc.29063
10.1093/annonc/mdq185
10.1016/j.oraloncology.2008.10.012
10.1016/j.amepre.2004.07.018
10.1016/j.oooo.2013.12.407
10.1016/0021-9681(87)90171-8
10.1016/j.lpm.2008.03.010
10.1016/j.canep.2010.04.012
10.1016/j.oraloncology.2011.02.013
10.1016/j.oraloncology.2013.10.016
10.1016/j.oraloncology.2004.09.008
10.1016/j.respe.2011.10.006
10.1016/j.ejca.2012.12.027
10.1136/jech-2011-200311
10.1016/j.oraloncology.2004.10.010
ContentType Journal Article
Copyright The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017
Copyright_xml – notice: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
– notice: Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000007285
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e7285
ExternalDocumentID PMC5500046
28658124
10_1097_MD_0000000000007285
00005792-201706300-00032
Genre Journal Article
Observational Study
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
.3C
.55
.GJ
1CY
53G
AAYXX
ADFPA
ADGHP
AE3
AFFNX
AFUWQ
AHRYX
BS7
BYPQX
CITATION
FW0
JF9
JG8
N4W
N~M
OCUKA
ODA
ORVUJ
OWU
P-K
R58
T8P
X7M
XXN
ZGI
ZXP
8L-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
7X8
5PM
ADSXY
ID FETCH-LOGICAL-c4052-8a41fc5597fb012af0c1a92274a8b54e34aeef67b24a1986012046045a8acfaa3
ISSN 0025-7974
1536-5964
IngestDate Thu Aug 21 18:24:15 EDT 2025
Fri Jul 11 10:59:31 EDT 2025
Wed Feb 19 02:30:25 EST 2025
Thu Apr 24 23:00:15 EDT 2025
Tue Jul 01 04:19:31 EDT 2025
Fri May 16 03:50:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 26
Language English
License This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4052-8a41fc5597fb012af0c1a92274a8b54e34aeef67b24a1986012046045a8acfaa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000007285
PMID 28658124
PQID 1914847533
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5500046
proquest_miscellaneous_1914847533
pubmed_primary_28658124
crossref_primary_10_1097_MD_0000000000007285
crossref_citationtrail_10_1097_MD_0000000000007285
wolterskluwer_health_00005792-201706300-00032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-June-01
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: 2017-June-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2017
Publisher The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved
Wolters Kluwer Health
Publisher_xml – name: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved
– name: Wolters Kluwer Health
References Reid (R16-32-20210309) 2004; 27
Conway (R6-32-20210309) 2015; 136
Grégoire (R9-32-20210309) 2010; 21
Ferlay (R1-32-20210309) 2013; 49
Ligier (R3-32-20210309) 2011; 47
Pornet (R13-32-20210309) 2012; 66
Tromp (R15-32-20210309) 2005; 41
De Camargo Cancela (R14-32-20210309) 2010; 34
Ligier (R4-32-20210309) 2012; 60
Scott (R18-32-20210309) 2005; 41
Stefanuto (R21-32-20210309) 2014; 117
Charlson (R12-32-20210309) 1987; 40
Teppo (R17-32-20210309) 2009; 45
Righini (R5-32-20210309) 2008; 37
Adrien (R19-32-20210309) 2014; 50
References_xml – volume: 136
  start-page: 1125
  year: 2015
  ident: R6-32-20210309
  article-title: Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29063
– volume: 21
  start-page: V184
  year: 2010
  ident: R9-32-20210309
  article-title: Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO. Clinical practice guidelines for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq185
– volume: 45
  start-page: 692
  year: 2009
  ident: R17-32-20210309
  article-title: Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2008.10.012
– volume: 27
  start-page: 373
  year: 2004
  ident: R16-32-20210309
  article-title: Comorbidity and early diagnosis of head and neck cancer in a Medicare population
  publication-title: Am J Prev Med
  doi: 10.1016/j.amepre.2004.07.018
– volume: 117
  start-page: 424
  year: 2014
  ident: R21-32-20210309
  article-title: Delays in treatment of oral cancer: a review of the current literature
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol
  doi: 10.1016/j.oooo.2013.12.407
– volume: 40
  start-page: 373
  year: 1987
  ident: R12-32-20210309
  article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
  publication-title: J Chronic Dis
  doi: 10.1016/0021-9681(87)90171-8
– volume: 37
  start-page: 1229
  year: 2008
  ident: R5-32-20210309
  article-title: Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx
  publication-title: Presse Med
  doi: 10.1016/j.lpm.2008.03.010
– volume: 34
  start-page: 501
  year: 2010
  ident: R14-32-20210309
  article-title: Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers
  publication-title: Cancer Epidemiol
  doi: 10.1016/j.canep.2010.04.012
– volume: 47
  start-page: 302
  year: 2011
  ident: R3-32-20210309
  article-title: Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2011.02.013
– volume: 50
  start-page: 90
  year: 2014
  ident: R19-32-20210309
  article-title: Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2013.10.016
– volume: 41
  start-page: 313
  year: 2005
  ident: R15-32-20210309
  article-title: Patient and tumour factors associated with advanced carcinomas of the head and neck
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2004.09.008
– volume: 60
  start-page: 131
  year: 2012
  ident: R4-32-20210309
  article-title: Elements of completeness and results of the first year of registration of the “Registre général des cancers de Lille et de sa région”
  publication-title: Rev Epidemiol Sante Publique
  doi: 10.1016/j.respe.2011.10.006
– volume: 49
  start-page: 1374
  year: 2013
  ident: R1-32-20210309
  article-title: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2012.12.027
– volume: 66
  start-page: 982
  year: 2012
  ident: R13-32-20210309
  article-title: Construction of an adaptable European transnational ecological deprivation index: the French version
  publication-title: J Epidemiol Commun Health
  doi: 10.1136/jech-2011-200311
– volume: 41
  start-page: 396
  year: 2005
  ident: R18-32-20210309
  article-title: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2004.10.010
SSID ssj0013724
Score 2.3455656
Snippet Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e7285
SubjectTerms Adult
Aged
Aged, 80 and over
Comorbidity
Female
France
Head and Neck Neoplasms - diagnosis
Head and Neck Neoplasms - epidemiology
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - therapy
Humans
Incidence
Male
Middle Aged
Neoplasm Staging
Observational Study
Odds Ratio
Registries
Young Adult
Title Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-201706300-00032
https://www.ncbi.nlm.nih.gov/pubmed/28658124
https://www.proquest.com/docview/1914847533
https://pubmed.ncbi.nlm.nih.gov/PMC5500046
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF1FrYSQEOLecKkWiTfjgDdrO-atbQJVRdsH2tI3a-yshWlwqiQWUv-X_2Bmd72Jm4IoeYgSry-R52R3ZjxnDmNvMEQOSDrEz0NJlByIfOgrjHnyQIGQYRxr-tjhUbR_Kg_Ow_NO59dK1VK9yHr51Y28kv-xKm5DuxJL9haWdSfFDfgZ7YvvaGF8_ycbD02dXGn6LP9wlSzWA9RdWL1K5RdU25UTVbesPPCoRbFPOXatJ-rBjNiSldHYsFT1S6fr5dM6N15pQ9vIP9mH8uSi7sJkUZqKXZdX-FSXVzCzRZOV8s9wJcKw3DvqOd9ZfSd46mnveFJq3suBG_0MdQUmnV4TZwyvtOcGd0HLI3lf8KpG_rvJXATxssKq13DfKA84nc17jgSgve6vU6oUmHuWKWAIWc2c6ZGoqc5c0HMVSl23WGBanjcxyj_NDG80cy2Sxep8rWJhFIPs4u--r60spmPx4dA0vLSv5dGtlt00FMaJ8IXuTtQ35P0-egqbAqMZnI43j89Go-HycVcspNMWxh_ftMdK4nc3XLHtQq3FRevlvfd-mht6oe_niv908oDdt4EP3zEofsg6qnrE7jQoeswqB2aOqOVLMPNpwQnMejOBmVsw87LiwNtg5gRmGjBg_sB3-HUocw3lJ-z04-hkb9-3YiB-jjEFrtoggyKn-LfI0KmC4n0eQCJELGGQhVL1JShVRHEmJATJICJSuIwwYIEB5AVA_ynbqKaV2mJcRiIpYgiDMSSyiMYZGmtcDDIMnrJBVkCXieb-prntlE-CLZO0qdg4HKbXjdJlb91Bl6ZRzN93f90YLsUJnZ7SQaWm9TylhovoMmIY1mXPjCHdCYlGTh55l8UtE7sdqFl8e6Qqv-mm8SEpn8ioy_wWGFJDt07_BNnnt9z_Bbu7_Ku_ZBuLWa1eodu-yLZ1umvbQv835WPl2A
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dj5QwEG_MXaImF-O3-FkTw5OoQKFgsg-bhXM9j9Vk9_R8IkNpc5vTsjn29N-3U1i89aKJvEBo4YGZdn7DzPyGkBfGRfaxdYgnIoYlORB7EErj8whfQsAizm35WDGLp0fs4Dg67rMtsBYGq8_a1Ss82X0aL7AfDjqGi9HB3J3lX-Yj7U7mk9FX99P4XW7_U2OWhJuNmh9q7Y5nNv8q4mlgdADpYcKuejo0W_VuHAXcLODdj5_zPPsdb-ABG5q7Goi94SdK-esi6zgO-4MH2Hb5og27BEwv51fu_Www9t2e2tT3CwZs_ya50SNPOu5U5Ra5IvVtcrXoY-t3iM66rLtlS0HX9PuQF0MbRc2WXdvbWopTKlBVzlq61BQoEh57-MfedielYFAoDtiOHfItHdPV0CPMQ5tZU0tpe5cc7eeLydTruzF4woA6s20C85VAB0RVxqqBeiN8SAPj1UJSRUyGDKRUMa8CBn6axFiVy2KDGCEBoQDCe2RHN1o-IJTFQao4RH4NKVNxXRlh1SqpDHqtkkqBQ4LN9y1FT1WOHTO-lZuQeZGVfwrFIS-Hh1YdU8e_pz_fCK40KwrDJKBlc96WyHhnbLbBwQ653wlyeCHW8SIkcgjfEvEwAdm6t0f08sSydkeRrdR1iLelDGVX71r-TWUf_uf8Z-TadFEclofvZx8ekes42mW2PSY767Nz-cRgqHX1tF8AvwAbFQ4p
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7ULRRBxLvxOoLkyYiZTG5CHpZN1lrdbWFbrU_hJJnBpZos3a3iv3fO5KJrRTAvCZlJCJnJnO_knPN9AM-1i-ySdIhT-oJKcjBw0JPa5yldiVz4YWjKx2bzYP9EHJz6pzvQR0yp-Gy9ekk7s0zTAcnhkF94nBws7Mliknyy59nHRTK3j8ZvMvObmpIk7KN0mvyw06T5pjZ2epj0_IyztCUp7LaQR_4V2I0iDeRHsHv4IcvSX3GHkItB5FVD7Z6n6O-32bZllwDq5TzLa98bioGvz0wK_G-GbHoDrncIlI3bKXMTdmR9C_ZmXYz9NtRpm323XDOsK_Z1yI9hjWJ66a7M6VqWZ6ykKXO-ZsuaISPiY4f-3BuVUoYajVKDUe6Qr9mYrQatMIdsZ8UMte0dOJlmx5N9p1NlcEoN7vTyicJVJTkiqtDWDdWr0sWYa-8Wo8IX0hMopQrCggt0Y_2WXU7BV-FjhKVC9O7CqG5qeR-YCHisQvTdCmOhgqrQ4LFSUaFRbBEVCi3g_fvNy46ynJQzvuR96HyW5n8OigUvhotWLWPHv7s_6wcu118WhUuwls3FOifmO227NR624F47kMMNqZ6XoJEF4dYQDx2ItXu7pV5-NuzdPklQiMACZ2sy5G3dq3k-P4y5Xr6I2chrC_89_uA_-z-FPf1B5O_fzt89hKvU2Ca4PYLR5vxCPtZQalM86eb_T1E8D70
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+and+management+of+head+and+neck+cancers+in+a+high-incidence+area+in+France%3A+A+population-based+study&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Guizard%2C+Anne-Valerie+N.&rft.au=Dejardin%2C+Olivier+J.&rft.au=Launay%2C+Ludivine+C.&rft.au=Bara%2C+Simona&rft.date=2017-06-01&rft.pub=The+Authors.+Published+by+Wolters+Kluwer+Health%2C+Inc.+All+rights+reserved&rft.issn=0025-7974&rft.volume=96&rft.issue=26&rft.spage=e7285&rft.epage=e7285&rft_id=info:doi/10.1097%2FMD.0000000000007285&rft.externalDocID=00005792-201706300-00032
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon